Figure 4.
Figure 4. Immunoblot analyses of CBFA2, pleckstrin, and PKC isozymes in platelets. (A) Immunoblot analysis of CBFA2 in platelets. Platelet lysates were subjected to SDS-PAGE and immunoblotting using an anti-CBFA2 antibody. Shown are the results in the patient (P) and 3 control subjects (N). (B) Immunoblot analysis of pleckstrin in platelets. Platelet lysates were subjected to SDS-PAGE and immunoblotting using an antipleckstrin antibody. Shown are the results in the patient (P), brother (B), sister (S), and 2 control subjects (N). 50% B and 50% N represent lanes with 50% protein applied. Pleckstrin levels are normal in the propositus. (C) Immunoblot analysis of PKC isozymes. The details are as described for panel B. PKC-θ levels were decreased in the patient (arrow). The results shown are representative of at least 3 separate experiments. To confirm that protein loading was comparable between the patient and the control subjects, the immunoblots used for PKC-θ were stripped and reblotted using antibodies against PKC-δ and PKC-ζ, which showed that the levels of these PKC in the patient were comparable to those of the other subjects (not shown).

Immunoblot analyses of CBFA2, pleckstrin, and PKC isozymes in platelets. (A) Immunoblot analysis of CBFA2 in platelets. Platelet lysates were subjected to SDS-PAGE and immunoblotting using an anti-CBFA2 antibody. Shown are the results in the patient (P) and 3 control subjects (N). (B) Immunoblot analysis of pleckstrin in platelets. Platelet lysates were subjected to SDS-PAGE and immunoblotting using an antipleckstrin antibody. Shown are the results in the patient (P), brother (B), sister (S), and 2 control subjects (N). 50% B and 50% N represent lanes with 50% protein applied. Pleckstrin levels are normal in the propositus. (C) Immunoblot analysis of PKC isozymes. The details are as described for panel B. PKC-θ levels were decreased in the patient (arrow). The results shown are representative of at least 3 separate experiments. To confirm that protein loading was comparable between the patient and the control subjects, the immunoblots used for PKC-θ were stripped and reblotted using antibodies against PKC-δ and PKC-ζ, which showed that the levels of these PKC in the patient were comparable to those of the other subjects (not shown).

Close Modal

or Create an Account

Close Modal
Close Modal